These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9692168)

  • 1. Successful treatment of human fascioliasis with nitazoxanide.
    Rossignol JF; Abaza H; Friedman H
    Trans R Soc Trop Med Hyg; 1998; 92(1):103-4. PubMed ID: 9692168
    [No Abstract]   [Full Text] [Related]  

  • 2. A study of a restricted programme of strategic dosing against Fasciola hepatica with triclabendazole.
    Fawcett AR
    Vet Rec; 1990 Nov; 127(20):492-3. PubMed ID: 2275087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fascioliasis in relatives of patients with Fasciola hepatica infection in Peru.
    Marcos L; Maco V; Terashima A; Samalvides F; Espinoza JR; Gotuzzo E
    Rev Inst Med Trop Sao Paulo; 2005; 47(4):219-22. PubMed ID: 16138205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oxyclozanide on feed efficiency in cattle with chronic fascioliasis.
    Knapp SE; Schlegel MW; Presidente PJ; Armstrong JN
    Am J Vet Res; 1971 Oct; 32(10):1583-7. PubMed ID: 5165559
    [No Abstract]   [Full Text] [Related]  

  • 5. [A case of chronic fascioliasis in a horse].
    Laber G
    Wien Tierarztl Monatsschr; 1971 Dec; 58(12):432-5. PubMed ID: 5171598
    [No Abstract]   [Full Text] [Related]  

  • 6. Anthelmintic efficacy of clioxanide against experimentally induced Fasciola hepatica infections in calves.
    Presidente PJ; Knapp SE; Schlegel MW; Armstrong JN
    Am J Vet Res; 1972 Aug; 33(8):1593-601. PubMed ID: 5047118
    [No Abstract]   [Full Text] [Related]  

  • 7. Unexpected production loss caused by helminth parasites in weaned beef calves.
    Sargison ND; Wilson DJ; Penny CD; Bartley DJ
    Vet Rec; 2010 Nov; 167(19):752-4. PubMed ID: 21257513
    [No Abstract]   [Full Text] [Related]  

  • 8. Fasciola hepatica: comparison of the sedimentation and FLOTAC techniques for the detection and quantification of faecal egg counts in rats.
    Duthaler U; Rinaldi L; Maurelli MP; Vargas M; Utzinger J; Cringoli G; Keiser J
    Exp Parasitol; 2010 Oct; 126(2):161-6. PubMed ID: 20434442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal egg count reduction test to detect lack of efficacy of triclabendazole.
    Daniel R; van Dijk J; Williams D
    Vet Rec; 2010 Nov; 167(19):759. PubMed ID: 21257517
    [No Abstract]   [Full Text] [Related]  

  • 10. Anthelmintic effect of rafoxanide against immature Fasciola hepatica in calves.
    Presidente PJ; Knapp SE
    Am J Vet Res; 1972 Aug; 33(8):1603-10. PubMed ID: 5047119
    [No Abstract]   [Full Text] [Related]  

  • 11. [Estimation of the spectrum of antihelminthic activity of VIVALIN (VIG-08)].
    Mikhaĭlitsyn FS; Koshevarov NI; Arkhipov IA; Eleev AB; Trusov SN; Sevbo DP
    Med Parazitol (Mosk); 2006; (1):57-9. PubMed ID: 16562754
    [No Abstract]   [Full Text] [Related]  

  • 12. Imported Fasciola hepatica infection in the United States and treatment with triclabendazole.
    Graham CS; Brodie SB; Weller PF
    Clin Infect Dis; 2001 Jul; 33(1):1-5. PubMed ID: 11389487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EFficacy of albendazole for treatment of naturally acquired fasciola hepatica in calves.
    Malone JB; Smith PH; Loyacano AF; Hembry FG; Brock LT
    Am J Vet Res; 1982 May; 43(5):879-81. PubMed ID: 7091853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired immunity to experimental infection with Fasciola hepatica in cattle.
    Doyle JJ
    Res Vet Sci; 1971 Nov; 12(6):527-34. PubMed ID: 5145349
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fasciola hepatica infection. Successful therapy using triclabendazole].
    Markwalder K; Koller M; Goebel N; Wolff K
    Schweiz Med Wochenschr; 1988 Jul; 118(27-28):1048-52. PubMed ID: 3413464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fascioliasis and intestinal parasitoses affecting schoolchildren in Atlixco, Puebla State, Mexico: epidemiology and treatment with nitazoxanide.
    Zumaquero-Ríos JL; Sarracent-Pérez J; Rojas-García R; Rojas-Rivero L; Martínez-Tovilla Y; Valero MA; Mas-Coma S
    PLoS Negl Trop Dis; 2013 Nov; 7(11):e2553. PubMed ID: 24278492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical tumor caused by the sexually mature stage of Fasciola hepatica.
    Marcos LA; Légua P; Sánchez J; Espinoza JR; Yi P; Tantaleán M
    Trans R Soc Trop Med Hyg; 2009 Mar; 103(3):318-20. PubMed ID: 19046753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of circulating Fasciola antigens and IgG4 isotype in assessment of cure from fascioliasis.
    Hegab MH; Hassan RM
    J Egypt Soc Parasitol; 2003 Aug; 33(2):561-70. PubMed ID: 14964667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasciola hepatica infection: clinical and radiological findings in pediatric patients.
    Karadağ-Öncel E; Ozsürekçi Y; Ozkaya-Parlakay A; Celik M; Cengiz AB; Haliloğlu M; Ceyhan M; Kara A
    Turk J Pediatr; 2012; 54(4):362-7. PubMed ID: 23692716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative kinetics of serological and coproantigen ELISA and faecal egg count in cattle experimentally infected with Fasciola hepatica and following treatment with triclabendazole.
    Brockwell YM; Spithill TW; Anderson GR; Grillo V; Sangster NC
    Vet Parasitol; 2013 Sep; 196(3-4):417-26. PubMed ID: 23643623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.